Kowal Investment Group LLC Invests $292,000 in HCA Healthcare, Inc. (NYSE:HCA)

Kowal Investment Group LLC purchased a new stake in shares of HCA Healthcare, Inc. (NYSE:HCA) during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 908 shares of the company’s stock, valued at approximately $292,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of HCA. Royal Bank of Canada raised its holdings in HCA Healthcare by 35.7% during the 4th quarter. Royal Bank of Canada now owns 4,503,918 shares of the company’s stock valued at $1,219,121,000 after buying an additional 1,183,890 shares during the period. Capital World Investors increased its stake in HCA Healthcare by 57.5% in the first quarter. Capital World Investors now owns 2,792,377 shares of the company’s stock worth $931,342,000 after purchasing an additional 1,019,750 shares during the period. Sanders Capital LLC lifted its position in shares of HCA Healthcare by 4.2% during the fourth quarter. Sanders Capital LLC now owns 11,404,003 shares of the company’s stock worth $3,086,836,000 after purchasing an additional 456,738 shares during the last quarter. Lee Danner & Bass Inc. bought a new stake in shares of HCA Healthcare during the second quarter worth $131,527,000. Finally, TD Asset Management Inc lifted its position in shares of HCA Healthcare by 230.5% during the fourth quarter. TD Asset Management Inc now owns 553,225 shares of the company’s stock worth $149,747,000 after purchasing an additional 385,854 shares during the last quarter. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have recently weighed in on the company. Robert W. Baird assumed coverage on HCA Healthcare in a research report on Thursday, May 30th. They set an “outperform” rating and a $396.00 target price for the company. Cantor Fitzgerald restated an “overweight” rating and set a $392.00 price target on shares of HCA Healthcare in a research note on Monday, August 19th. UBS Group raised their price target on HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research note on Wednesday, August 14th. Oppenheimer raised their price target on HCA Healthcare from $345.00 to $390.00 and gave the company an “outperform” rating in a research note on Wednesday, July 24th. Finally, Baird R W upgraded HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Five analysts have rated the stock with a hold rating, fourteen have issued a buy rating and three have given a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $359.89.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the transaction, the executive vice president now directly owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the business’s stock in a transaction that occurred on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares in the company, valued at $3,436,623.54. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the completion of the sale, the executive vice president now owns 29,678 shares of the company’s stock, valued at $11,438,494.76. The disclosure for this sale can be found here. Insiders sold 17,202 shares of company stock valued at $6,407,273 over the last quarter. 1.60% of the stock is currently owned by company insiders.

HCA Healthcare Price Performance

Shares of HCA stock opened at $404.66 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $405.70. The firm has a market capitalization of $105.99 billion, a price-to-earnings ratio of 20.17, a PEG ratio of 1.46 and a beta of 1.67. The company has a debt-to-equity ratio of 27.11, a quick ratio of 0.94 and a current ratio of 1.06. The stock’s 50-day simple moving average is $370.57 and its 200-day simple moving average is $340.65.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, July 23rd. The company reported $5.50 earnings per share for the quarter, topping analysts’ consensus estimates of $4.97 by $0.53. HCA Healthcare had a return on equity of 553.13% and a net margin of 8.40%. The business had revenue of $17.49 billion for the quarter, compared to analyst estimates of $17.05 billion. During the same quarter in the previous year, the firm earned $4.29 earnings per share. The company’s revenue was up 10.3% on a year-over-year basis. As a group, equities analysts forecast that HCA Healthcare, Inc. will post 22.46 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Monday, September 16th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.65%. The ex-dividend date is Monday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.